Hudson Valley Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$253K Hold
700
0.03% 134
2026
Q1
$246K Sell
700
-2
-0.3% -$713 0.03% 137
2025
Q4
$230K Sell
702
-548
-44% -$174K 0.03% 144
2025
Q3
$353K Sell
1,250
-18
-1% -$5.22K 0.04% 136
2025
Q2
$354K Buy
1,268
+18
+1% +$5.1K 0.04% 135
2025
Q1
$389K Hold
1,250
0.05% 126
2024
Q4
$326K Hold
1,250
0.04% 138
2024
Q3
$403K Sell
1,250
-510
-29% -$167K 0.04% 132
2024
Q2
$547K Buy
1,760
+510
+41% +$150K 0.07% 124
2024
Q1
$355K Sell
1,250
-510
-29% -$149K 0.04% 140
2023
Q4
$547K Buy
1,760
+60
+4% +$16.3K 0.07% 124
2023
Q3
$457K Sell
1,700
-524
-24% -$131K 0.06% 136
2023
Q2
$494K Buy
2,224
+10
+0.5% +$2.32K 0.07% 141
2023
Q1
$535K Hold
2,214
0.07% 138
2022
Q4
$581K Hold
2,214
0.09% 130
2022
Q3
$499K Sell
2,214
-141
-6% -$34.2K 0.08% 134
2022
Q2
$573K Sell
2,355
-100
-4% -$24.5K 0.09% 130
2022
Q1
$594K Sell
2,455
-30
-1% -$6.89K 0.08% 134
2021
Q4
$559K Sell
2,485
-100
-4% -$21.1K 0.09% 124
2021
Q3
$550K Hold
2,585
0.09% 115
2021
Q2
$630K Sell
2,585
-335
-11% -$82.4K 0.11% 111
2021
Q1
$727K Sell
2,920
-125
-4% -$29.8K 0.13% 102
2020
Q4
$700K Hold
3,045
0.13% 101
2020
Q3
$774K Sell
3,045
-223
-7% -$55.2K 0.17% 93
2020
Q2
$771K Sell
3,268
-369
-10% -$84.2K 0.18% 94
2020
Q1
$737K Sell
3,637
-1,009
-22% -$220K 0.2% 88
2019
Q4
$1.12M Buy
4,646
+50
+1% +$11K 0.24% 81
2019
Q3
$889K Sell
4,596
-249
-5% -$47.8K 0.21% 94
2019
Q2
$893K Sell
4,845
-6,159
-56% -$1.1M 0.21% 94
2019
Q1
$2.09M Sell
11,004
-4,062
-27% -$776K 0.51% 57
2018
Q4
$2.93M Buy
15,066
+3,169
+27% +$618K 0.68% 50
2018
Q3
$2.47M Sell
11,897
-269
-2% -$53K 0.57% 53
2018
Q2
$2.25M Buy
12,166
+445
+4% +$78.7K 0.55% 56
2018
Q1
$2M Buy
11,721
+693
+6% +$127K 0.5% 59
2017
Q4
$1.92M Buy
11,028
+56
+0.5% +$9.91K 0.47% 63
2017
Q3
$2.05M Buy
10,972
+16
+0.1% +$2.83K 0.53% 58
2017
Q2
$1.89M Sell
10,956
-439
-4% -$71.4K 0.52% 59
2017
Q1
$1.87M Buy
11,395
+400
+4% +$66.5K 0.52% 60
2016
Q4
$1.61M Buy
10,995
+2,206
+25% +$332K 0.47% 63
2016
Q3
$1.47M Buy
8,789
+326
+4% +$55.1K 0.46% 65
2016
Q2
$1.29M Sell
8,463
-490
-5% -$76.2K 0.41% 68
2016
Q1
$1.34M Buy
8,953
+231
+3% +$34.3K 0.44% 63
2015
Q4
$1.42M Sell
8,722
-494
-5% -$77.7K 0.44% 59
2015
Q3
$1.27M Buy
9,216
+65
+0.7% +$10.2K 0.41% 59
2015
Q2
$1.41M Buy
9,151
+966
+12% +$155K 0.44% 61
2015
Q1
$1.31M Buy
8,185
+2,155
+36% +$339K 0.44% 60
2014
Q4
$960K Buy
6,030
+371
+7% +$57.8K 0.39% 62
2014
Q3
$795K Buy
5,659
+375
+7% +$49K 0.34% 66
2014
Q2
$625K Buy
5,284
+406
+8% +$47K 0.27% 72
2014
Q1
$602K Buy
4,878
+35
+0.7% +$4.25K 0.26% 72
2013
Q4
$552K Buy
4,843
+226
+5% +$25.7K 0.24% 72
2013
Q3
$517K Sell
4,617
-525
-10% -$56.9K 0.25% 72
2013
Q2
$507K Buy
+5,142
New +$534K 0.24% 74

Other funds holding AMGN

Hudson Valley Investment Advisors's AMGN Position: Q2 2026 in Review

Hudson Valley Investment Advisors held its Amgen (AMGN) position steady in Q2 2026 at 700 shares worth $253K. The position accounts for 0.03% of the portfolio, ranked #134.

Hudson Valley Investment Advisors first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.93M in Q4 2018. 1,262 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Hudson Valley Investment Advisors held 700 shares of Amgen worth $253K as of Q2 2026.
  • Hudson Valley Investment Advisors left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.03% of Hudson Valley Investment Advisors's portfolio in Q2 2026, its #134 holding.
  • Hudson Valley Investment Advisors first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Hudson Valley Investment Advisors's Amgen position peaked at $2.93M in Q4 2018.
  • 1,262 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Hudson Valley Investment Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.